Jian-Yong Li (Jianyong Li, Li Jian-Yong)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Chronic Lymphocytic Leukemia

Hepatitis B Virus

Diffuse Large B Cell Lymphoma

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cancer medicine

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Miao, Jing Zhang, Xuzhang Lu, Meng Wu, Bingzong Li, Liang Yu, Miao Sun, Yun Zhuang, Yuqing Miao, Haiwen Ni, Xiaoyan Xie, Jingyan Xu, Yunping Zhang, Min Zhao, Min Xu, Wanchuan Zhuang, Weiying Gu, Guoqiang Lin, Haiying Hua, Jianfeng Zhu, Maozhong Xu, Tao Jia, Ping Liu, Lijia Zhai, Tongtong Zhang, Qiurong Shan, Qiudan Shen, Jun Qian, Chunling Wang, Jian-Yong Li, Wenyu Shi
Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma-associated hemophagocytic lymphohistiocytosis: A multicenter analysis. Cancer medicine 13 (16) (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Jin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao, Wei Hua, Chun-Yu Shang, Kai-Xin Du, Tong-Yao Xing, Xin-Yu Zhang, Chen-Xuan Wang, Liu-Qing Zhu, Yang W Shao, Jian-Yong Li, Jia-Zhu Wu, Hua Yin, Li Wang, Wei Xu
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia 38 (7) (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Jin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao, Wei Hua, Chun-Yu Shang, Kai-Xin Du, Tong-Yao Xing, Xin-Yu Zhang, Chen-Xuan Wang, Liu-Qing Zhu, Yang W Shao, Jian-Yong Li, Jia-Zhu Wu, Hua Yin, Li Wang, Wei Xu
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia 38 (7) (2024)
Shuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, Yan Hu, Feiyan Zhang, Zejuan Gu, Wei Xu, Lei Fan, Yi Miao, Jian-Yong Li
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57 (2024)
Jin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao, Wei Hua, Chun-Yu Shang, Kai-Xin Du, Tong-Yao Xing, Xin-Yu Zhang, Chen-Xuan Wang, Liu-Qing Zhu, Yang W Shao, Jian-Yong Li, Jia-Zhu Wu, Hua Yin, Li Wang, Wei Xu
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia (2024)
Hailing Liu, Zhen He, Renfu Gui, Jingjing Guo, Lvwen Chen, Miao Zhong, Jian-Yong Li, Lei Cao, Lei Fan
Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients. British journal of haematology (2023)
Xueying Lu, Shunan Wang, Xin Hua, Xiao Chen, Mengtao Zhan, Qiaoyun Hu, Lei Cao, Zijuan Wu, Wei Zhang, Xiaoling Zuo, Renfu Gui, Lei Fan, Jian-Yong Li, Wenyu Shi, Hui Jin
Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (10) (2023)
Xueying Lu, Shunan Wang, Xin Hua, Xiao Chen, Mengtao Zhan, Qiaoyun Hu, Lei Cao, Zijuan Wu, Wei Zhang, Xiaoling Zuo, Renfu Gui, Lei Fan, Jian-Yong Li, Wenyu Shi, Hui Jin
Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (10) (2023)
Hailing Liu, Jingjing Guo, Lei Cao, Huayuan Zhu, Yi Miao, Xinyi Du, Yujie Wu, Wei Xu, Jian-Yong Li, Lei Fan
A simplified prognostic score for T-cell large granular lymphocyte leukaemia. Annals of medicine 55 (2) (2023)
Xueying Lu, Shunan Wang, Xin Hua, Xiao Chen, Mengtao Zhan, Qiaoyun Hu, Lei Cao, Zijuan Wu, Wei Zhang, Xiaoling Zuo, Renfu Gui, Lei Fan, Jian-Yong Li, Wenyu Shi, Hui Jin
Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (10) (2023)
Xueying Lu, Shunan Wang, Xin Hua, Xiao Chen, Mengtao Zhan, Qiaoyun Hu, Lei Cao, Zijuan Wu, Wei Zhang, Xiaoling Zuo, Renfu Gui, Lei Fan, Jian-Yong Li, Wenyu Shi, Hui Jin
Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (10) (2023)
Yi Miao, Yeqin Sha, Yi Xia, Shuchao Qin, Rui Jiang, Luomengjia Dai, Hui Shen, Tonglu Qiu, Wei Wu, Jingyan Qiu, Yilian Yang, Chongyang Ding, Yujie Wu, Lei Fan, Wei Xu, Jian-Yong Li, Huayuan Zhu
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort. Blood cancer journal 13 (1) (2023)
Jing Wang, Na Shen, Xuxing Shen, Run Zhang, Yuanyuan Jin, Jian-Yong Li, Lijuan Chen
Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease. Annals of medicine 55 (2) (2023)
Xueying Lu, Shunan Wang, Xin Hua, Xiao Chen, Mengtao Zhan, Qiaoyun Hu, Lei Cao, Zijuan Wu, Wei Zhang, Xiaoling Zuo, Renfu Gui, Lei Fan, Jian-Yong Li, Wenyu Shi, Hui Jin
Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell Lymphoma Progression and Enhances the Chemotherapeutic Efficacy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Jing-Jing Guo, Lei Cao, Hua-Yuan Zhu, Yi Miao, Xin-Yi Du, Yu-Jie Wu, Li Wang, Wei Xu, Jian-Yong Li, Lei Fan
T-cell large granular lymphocytic leukaemia with atypical immunophenotypes: A single-centre retrospective analysis of 17 cases. British journal of haematology 198 (2) (2022)
Wenjie Liu, Zijuan Wu, Yan Yu, Chun Qiao, Han Zhu, Ming Hong, Yu Zhu, Sixuan Qian, Suning Chen, Depei Wu, Jian-Yong Li, Hui Jin
Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia. Oxidative medicine and cellular longevity 2022 (2022)
Wei Xu, Shenmiao Yang, Constantine S Tam, John F Seymour, Keshu Zhou, Stephen Opat, Lugui Qiu, Mingyuan Sun, Tingyu Wang, Judith Trotman, Ling Pan, Sujun Gao, Jianfeng Zhou, Daobin Zhou, Jun Zhu, Yuqin Song, Jianda Hu, Ru Feng, Haiwen Huang, Dan Su, Miao Shi, Jian-Yong Li
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies. Advances in therapy 39 (9) (2022)
Yi-Min Ren, Chun-Yu Shang, Jin-Hua Liang, Hua Yin, Yi Xia, Jia-Zhu Wu, Li Wang, Jian-Yong Li, Yue Li, Wei Xu
Prognostic significance of serum immunoglobulin paraprotein in mucosa-associated lymphoid tissue (MALT) lymphoma. British journal of haematology 196 (6) (2021)
Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Jianfeng Zhou, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Meng Ji, Haiyi Guo, Jane Huang, William Novotny, Shibao Feng, Jian-Yong Li
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study. Journal of hematology & oncology 13 (1) (2020)
Xuxing Shen, Shu Liu, Chao Wu, Jing Wang, Jian-Yong Li, Lijuan Chen
Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study. Cancer medicine 10 (2) (2020)
Ke Shi, Qian Sun, Chun Qiao, Huayuan Zhu, Li Wang, Jiazhu Wu, Lili Wang, Jianxin Fu, Ken H Young, Lei Fan, Yi Xia, Wei Xu, Jian-Yong Li
98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia. Cancer medicine 9 (3) (2019)
Yi Miao, Xiao-Hui Zhou, Jing-Jing Guo, Qian Sun, Ke Shi, Jia-Zhu Wu, Hua-Yuan Zhu, Li Wang, Lei Fan, Wei Xu, Jian-Yong Li
Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma. Cancer medicine 8 (6) (2019)
Yixin Zou, Wei Xu, Jian-Yong Li
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia. Journal of hematology & oncology 11 (1) (2018)